张崇敬, 张志辉, 徐柏玲, 王玉玲. Pin1及其抑制剂的研究进展J. 药学学报, 2008, 43(1): 9-9.
引用本文: 张崇敬, 张志辉, 徐柏玲, 王玉玲. Pin1及其抑制剂的研究进展J. 药学学报, 2008, 43(1): 9-9.
ZHANG Chong-jing, ZHANG Zhi-hui, XU Bai-ling WANG Yu-ling, . Recent advances in the study of Pin1 and its inhibitorsJ. Acta Pharmaceutica Sinica, 2008, 43(1): 9-9.
Citation: ZHANG Chong-jing, ZHANG Zhi-hui, XU Bai-ling WANG Yu-ling, . Recent advances in the study of Pin1 and its inhibitorsJ. Acta Pharmaceutica Sinica, 2008, 43(1): 9-9.

Pin1及其抑制剂的研究进展

Recent advances in the study of Pin1 and its inhibitors

  • 摘要: Pin1是一个新的肽脯氨酰异构酶,特异性地催化蛋白质中磷酸化的Ser/Thr-Pro酰胺键的顺反异构,改变蛋白质的构象,调控蛋白质的功能。抑制Pin1的表达和活性,可抑制肿瘤细胞的生长。Pin1抑制剂有望发展成为新作用机制的抗癌药物。本文综述了近年来Pin1及其抑制剂研究的最新进展。

     

    Abstract: Pin1 is a phosphorylation-dependent peptidyl-prolyl cis/trans isomerase, which specifically catalyzes the amide bond isomerization of phosphoserine-proline or phosphothreonine-proline in mitotic phosphoproteins. Pin1 induces the conformational changes to control the function of phosphoproteins. Depletion of Pin1 on various human cancer cell lines cause mitotic arrest and apoptosis. Pin1 is an attracting therapeutic target for anticancer and its inhibitors might be potential anticancer drug. In this review, Pin1 inhibitors and the catalytic mechanism, the biological function of Pin1 and its role in oncogenesis are summarized.

     

/

返回文章
返回